Alx Oncology Holdings (ALXO) Non-Current Deffered Revenue (2019)
Alx Oncology Holdings' Non-Current Deffered Revenue history spans 1 years, with the latest figure at $135000.0 for Q4 2019.
- For Q4 2019, Non-Current Deffered Revenue changed N/A year-over-year to $135000.0; the TTM value through Dec 2019 reached $135000.0, changed N/A, while the annual FY2019 figure was $135000.0, N/A changed from the prior year.
- Non-Current Deffered Revenue for Q4 2019 was $135000.0 at Alx Oncology Holdings.
- Across five years, Non-Current Deffered Revenue topped out at $135000.0 in Q4 2019 and bottomed at $135000.0 in Q4 2019.